Ontario Drug Benefit coverage for Ozempic, Mounjaro, Wegovy and Zepbound
By GLP1Prices Editorial · Plan rules checked November 13, 2026 · Sources under each section
Is Ozempic, Wegovy, Mounjaro or Zepbound covered by OHIP?
OHIP pays for none of them. Its list of what it does not cover includes "prescription drugs provided in non-hospital settings". Ontario's drug plan is the Ontario Drug Benefit (ODB) program. It covers people 65 and older, people 24 and under with no private plan (OHIP+), households in the Trillium Drug Program and several other groups. Its answer for each drug:
Sources: ontario.ca: What OHIP covers (page dated November 9, 2026) (read November 13, 2026); ontario.ca: Get coverage for prescription drugs (Ontario Drug Benefit program; page dated August 18, 2026) (read November 11, 2026)
Ozempic: Only if you are on the ODB program, the criteria published for the pen's Limited Use code (665, 666 or 667) are met, and your prescriber gives that code with the prescription.
Sources: Ontario e-Formulary: search for semaglutide (Formulary effective from October 30, 2026) (read November 13, 2026); Ontario e-Formulary: Limited Use note, Reason For Use code 665 (semaglutide 1.34 mg/mL 3 mL pen) (read November 13, 2026); Ontario e-Formulary: Limited Use note, Reason For Use code 666 (semaglutide 1.34 mg/mL 1.5 mL pen) (read November 13, 2026); Ontario e-Formulary: Limited Use note, Reason For Use code 667 (semaglutide 0.68 mg/mL 3 mL pen) (read November 13, 2026); Ontario Drug Benefit Formulary/Comparative Drug Index, Edition 43 (October 27, 2026 version) (read November 11, 2026)
Generic semaglutide (Apo-Semaglutide, Dr. Reddy's): Only if the same Limited Use criteria are met and your prescriber gives the same code as for the matching Ozempic pen.
Sources: Ontario e-Formulary: search for semaglutide (Formulary effective from October 30, 2026) (read November 13, 2026); Ontario e-Formulary: Limited Use note, Reason For Use code 665 (semaglutide 1.34 mg/mL 3 mL pen) (read November 13, 2026); Ontario e-Formulary: Limited Use note, Reason For Use code 666 (semaglutide 1.34 mg/mL 1.5 mL pen) (read November 13, 2026); Ontario e-Formulary: Limited Use note, Reason For Use code 667 (semaglutide 0.68 mg/mL 3 mL pen) (read November 13, 2026)
Mounjaro: No. It is not on the ODB Formulary. Ontario's Check medication coverage tool also searches the Exceptional Access Program list and finds no Mounjaro or tirzepatide.
Sources: Ontario e-Formulary: searches for tirzepatide (generic name), Mounjaro and Zepbound (brand name) (read November 11, 2026); ontario.ca: Check medication coverage (searches for Mounjaro, Zepbound, tirzepatide, Wegovy and Ozempic; page dated October 9, 2026) (read November 11, 2026)
Wegovy: No. The e-Formulary lists it as Off-Formulary Interchangeable, the status for products that are not ODB benefits. Ontario's Check medication coverage tool shows it as not covered.
Sources: Ontario e-Formulary: Wegovy 4mg/3mL pen, DIN 02528525, product details (read November 13, 2026); Ontario Drug Benefit Formulary/Comparative Drug Index, Edition 43 (October 27, 2026 version) (read November 11, 2026); ontario.ca: Check medication coverage (searches for Mounjaro, Zepbound, tirzepatide, Wegovy and Ozempic; page dated October 9, 2026) (read November 11, 2026)
Zepbound: No. It is not on the ODB Formulary, and Ontario's Check medication coverage tool finds no Zepbound.
Sources: Ontario e-Formulary: searches for tirzepatide (generic name), Mounjaro and Zepbound (brand name) (read November 11, 2026); ontario.ca: Check medication coverage (searches for Mounjaro, Zepbound, tirzepatide, Wegovy and Ozempic; page dated October 9, 2026) (read November 11, 2026)
The short answer
OHIP doesn't pay for prescription drugs you get outside a hospital. Ontario's drug plan is the Ontario Drug Benefit (ODB) program, for people 65 and older, people 24 and under with no private plan (OHIP+), households enrolled in the Trillium Drug Program and several other groups. On its Formulary, Ozempic and generic semaglutide are Limited Use drugs: the program pays only under the criteria published for each pen's Reason for Use code (665, 666 or 667), which your prescriber gives with the prescription. Mounjaro and Zepbound are not on the Formulary, and Wegovy is listed only as Off-Formulary Interchangeable, which is not a benefit. Without coverage you pay the pharmacy's price: the lowest prices we list in Ontario are below.
Sources: ontario.ca: What OHIP covers (page dated November 9, 2026) (read November 13, 2026); ontario.ca: Get coverage for prescription drugs (Ontario Drug Benefit program; page dated August 18, 2026) (read November 11, 2026); Ontario e-Formulary: search for semaglutide (Formulary effective from October 30, 2026) (read November 13, 2026); Ontario e-Formulary: searches for tirzepatide (generic name), Mounjaro and Zepbound (brand name) (read November 11, 2026); Ontario Drug Benefit Formulary/Comparative Drug Index, Edition 43 (October 27, 2026 version) (read November 11, 2026)
What you pay without coverage in Ontario
The ODB program does not cover "drugs that are not listed on the official Ontario Drug Benefit Formulary/Comparative Drug Index, or are not approved by the Exceptional Access Program". For those drugs, and for anyone who is not on the program, the pharmacy's price applies unless another plan pays. These are the lowest prices we list in Ontario, with the pharmacy and the date the price was last updated.
Source: ontario.ca: Get coverage for prescription drugs (Ontario Drug Benefit program; page dated August 18, 2026) (read November 11, 2026)
| Drug | Public plan status | Lowest price we list in Ontario |
|---|---|---|
| Ozempic | Limited Use: Reason for Use codes 665, 666 and 667 | $241 at Costco Pharmacy2mg/1.34mL pen, 1 pen · Updated November 20268 pharmacies listed |
| Generic semaglutide (Apo-Semaglutide) | Limited Use: Reason for Use codes 665, 666 and 667 | $88 at Costco Pharmacy2mg/3mL pen, 1 pen · Updated November 20265 pharmacies listed |
| Mounjaro | Not on the ODB Formulary | $288 at Costco Pharmacy2.5mg/0.6mL pen, 1 pen · Updated November 20265 pharmacies listed |
| Wegovy | Off-Formulary Interchangeable: not a benefit | $297 at Costco Pharmacy0.25mg pen, 1 pen · Updated November 20266 pharmacies listed |
| Zepbound | Not on the ODB Formulary | $319.67 at Walmart Pharmacy2.5mg/0.6mL pen, 1 pen · Updated November 20268 pharmacies listed |
Status from the plan's own lists (sources under each section below). Prices are the lowest active price we list per drug in Ontario, before any plan or savings card; a pharmacy may add a dispensing fee.
How the Ontario Drug Benefit program decides what it pays
The Ontario Drug Benefit (ODB) program "covers most of the cost" of the drugs on its Formulary for the people who qualify. You join automatically on the first day of the month after you turn 65. Before 65, you may qualify if you live in a long-term care home or a Community Home for Opportunity, are 24 or younger and not covered by a private insurance plan (through OHIP+), receive professional home and community care services, receive Ontario Works or Ontario Disability Support Program benefits, or are enrolled in the Trillium Drug Program. The program is for Ontario residents only, and "prescriptions must be filled in an Ontario pharmacy to be covered".
Source: ontario.ca: Get coverage for prescription drugs (Ontario Drug Benefit program; page dated August 18, 2026) (read November 11, 2026)
OHIP+ covers "anyone age 24 years or younger who is not covered by a private plan". There is nothing to enrol in, the pharmacy fills a covered prescription at no charge, and coverage stops on your 25th birthday or when a private plan covers you. The Trillium Drug Program is for households whose prescription-drug costs are high compared to their income: among its conditions, you don't already qualify for the ODB program and you don't have "an insurance plan that pays for 100% of your drugs". Once you have paid the deductible, "usually about 4% of your household income after taxes", Trillium covers the drugs the ODB program covers, with a co-payment for each drug filled or refilled.
Sources: ontario.ca: Learn about OHIP+ (page dated February 11, 2026) (read November 11, 2026); ontario.ca: Trillium Drug Program, who should apply and what you pay (page dated February 11, 2026) (read November 11, 2026)
What you pay depends on how you qualify. Unless they qualify another way or are in the Seniors Co-Payment Program, seniors pay a deductible each program year (August 1 to July 31), then a co-payment for each prescription filled or refilled. The Seniors Co-Payment Program, for seniors under its income thresholds, has no deductible and a lower co-payment.
Source: ontario.ca: Get coverage for prescription drugs (Ontario Drug Benefit program; page dated August 18, 2026) (read November 11, 2026)
The program pays for drugs listed on the ODB Formulary and for drugs approved case by case through the Exceptional Access Program (EAP). It does not cover "drugs that are not listed on the official Ontario Drug Benefit Formulary/Comparative Drug Index, or are not approved by the Exceptional Access Program". A Limited Use drug is "covered only under special medical circumstances": the Formulary publishes criteria for it, and your doctor or nurse practitioner confirms that they apply "by writing a three-digit code on your prescription, called the Reason for Use code".
Sources: ontario.ca: Get coverage for prescription drugs (Ontario Drug Benefit program; page dated August 18, 2026) (read November 11, 2026); Ontario Drug Benefit Formulary/Comparative Drug Index, Edition 43 (October 27, 2026 version) (read November 11, 2026)
For a drug that isn't on the Formulary, "you may get help paying for selected drugs when you make a request for case-by-case consideration through the Exceptional Access Program". You must be on the ODB program, only a doctor or nurse practitioner can apply, and the EAP considers a request only for a drug Ontario has decided to fund through it. Ontario says a decision takes 3 days to 6 weeks; if you fill the prescription first and the request is not approved, you "will not receive any coverage of your out-of-pocket costs".
Sources: ontario.ca: Applying to the Exceptional Access Program (page dated October 20, 2025) (read November 11, 2026); ontario.ca: Exceptional Access Program, information for health care professionals (page dated November 9, 2026) (read November 11, 2026)
OHIP covers medically necessary visits to a doctor, in person or by video or telephone. Its list of what it does not cover includes "prescription drugs provided in non-hospital settings".
Source: ontario.ca: What OHIP covers (page dated November 9, 2026) (read November 13, 2026)
Ozempic and generic semaglutide in Ontario
Status: Limited Use: Reason for Use codes 665, 666 and 667
On the e-Formulary, the searchable version of the ODB Formulary (effective from October 30, 2026), three Ozempic pens are Limited Use products: the 1.34 mg/mL 3 mL pen (DIN 02471469), the 1.34 mg/mL 1.5 mL pen (DIN 02471477) and the 0.68 mg/mL 3 mL pen (DIN 02540258). The generic semaglutide pens from Apotex (Apo-Semaglutide Injection, DINs 02568012 and 02568020) and Dr. Reddy's (DINs 02567806 and 02567814), listed on June 30, 2026, are Limited Use products too.
Source: Ontario e-Formulary: search for semaglutide (Formulary effective from October 30, 2026) (read November 13, 2026)
Each pen has its own Reason for Use code, brand or generic: 665 for the 1.34 mg/mL 3 mL pens, 666 for the 1.34 mg/mL 1.5 mL pens and 667 for the 0.68 mg/mL 3 mL pens. The e-Formulary publishes the criteria for each code on its Limited Use note (linked below) and gives the LU authorization period as "Indefinite". The ODB program reimburses a Limited Use product only when those criteria are met and the prescriber has given the Reason for Use code with the prescription.
Sources: Ontario e-Formulary: Limited Use note, Reason For Use code 665 (semaglutide 1.34 mg/mL 3 mL pen) (read November 13, 2026); Ontario e-Formulary: Limited Use note, Reason For Use code 666 (semaglutide 1.34 mg/mL 1.5 mL pen) (read November 13, 2026); Ontario e-Formulary: Limited Use note, Reason For Use code 667 (semaglutide 0.68 mg/mL 3 mL pen) (read November 13, 2026); Ontario Drug Benefit Formulary/Comparative Drug Index, Edition 43 (October 27, 2026 version) (read November 11, 2026)
Ozempic and the generic pens are interchangeable on the Formulary, and the ODB program reimburses "the lowest DBP within an interchangeable category" (DBP is the Drug Benefit Price). The e-Formulary shows the same "Amount MOH Pays" for an Ozempic pen as for its generic. Ontario.ca puts the rule this way: "You can get covered for either the brand-name or the generic drug, whichever costs less." The ministry pays for a higher-cost interchangeable product only in the medically necessary "No Substitution" cases the Formulary describes.
Sources: Ontario e-Formulary: interchangeable grouping of the semaglutide 1.34 mg/mL 3 mL pens (Ozempic DIN 02471469) (read November 11, 2026); Ontario Drug Benefit Formulary/Comparative Drug Index, Edition 43 (October 27, 2026 version) (read November 11, 2026); ontario.ca: Get coverage for prescription drugs (Ontario Drug Benefit program; page dated August 18, 2026) (read November 11, 2026)
Ozempic prices in Ontario · Generic semaglutide (Apo-Semaglutide) prices in Ontario
Mounjaro in Ontario
Status: Not on the ODB Formulary
The e-Formulary has no Mounjaro or tirzepatide product: a search by brand name or by generic name returns "No drugs found for selected criteria." Ontario's Check medication coverage tool, which searches the ODB Formulary and the Exceptional Access Program list, finds no Mounjaro or tirzepatide either.
Sources: Ontario e-Formulary: searches for tirzepatide (generic name), Mounjaro and Zepbound (brand name) (read November 11, 2026); ontario.ca: Check medication coverage (searches for Mounjaro, Zepbound, tirzepatide, Wegovy and Ozempic; page dated October 9, 2026) (read November 11, 2026); Health Canada Drug Product Database: Mounjaro KwikPen, DIN 02551950 (tirzepatide; Schedule: Prescription) (read November 11, 2026)
There is no Limited Use code for Mounjaro, and it is not on Ontario's list of the most common Exceptional Access Program drug products (September 2026 update; the list says it is not comprehensive). The ODB program does not cover "drugs that are not listed on the official Ontario Drug Benefit Formulary/Comparative Drug Index, or are not approved by the Exceptional Access Program", so you pay the pharmacy price unless another plan covers it. When its tool finds nothing, Ontario says it could mean the medication "is not on the Ontario Drug Benefit (ODB) Formulary or the Exceptional Access Program (EAP) list" or "is new or is being reviewed to decide if it should be added to the ODB Formulary or EAP list".
Sources: Ontario e-Formulary: searches for tirzepatide (generic name), Mounjaro and Zepbound (brand name) (read November 11, 2026); Ontario Exceptional Access Program: EAP Drug List with Drug Identification Numbers (September 2026 update) (read November 11, 2026); ontario.ca: Get coverage for prescription drugs (Ontario Drug Benefit program; page dated August 18, 2026) (read November 11, 2026); ontario.ca: Check medication coverage (searches for Mounjaro, Zepbound, tirzepatide, Wegovy and Ozempic; page dated October 9, 2026) (read November 11, 2026)
Wegovy in Ontario
Status: Off-Formulary Interchangeable: not a benefit
The e-Formulary lists one Wegovy pen (DIN 02528525), with the coverage status Off-Formulary Interchangeable and "N/A" as the amount the ministry pays. The Formulary applies that status "to drug products that are not listed as ODB benefits" and says none of the products listed that way "are formulary benefits". It adds that some of them "may be covered under the ODB program through the EAP"; Ontario's Check medication coverage tool returns Wegovy as not covered, and Ontario's list of the most common EAP drug products has no semaglutide product.
Sources: Ontario e-Formulary: Wegovy 4mg/3mL pen, DIN 02528525, product details (read November 13, 2026); Ontario Drug Benefit Formulary/Comparative Drug Index, Edition 43 (October 27, 2026 version) (read November 11, 2026); ontario.ca: Check medication coverage (searches for Mounjaro, Zepbound, tirzepatide, Wegovy and Ozempic; page dated October 9, 2026) (read November 11, 2026); Ontario Exceptional Access Program: EAP Drug List with Drug Identification Numbers (September 2026 update) (read November 11, 2026)
Zepbound in Ontario
Status: Not on the ODB Formulary
Zepbound is tirzepatide too. The e-Formulary returns "No drugs found for selected criteria." for Zepbound, and Ontario's Check medication coverage tool finds no Zepbound. A drug that is not on the Formulary and not approved through the Exceptional Access Program is not covered by the ODB program.
Sources: Health Canada Drug Product Database: Zepbound, DIN 02557509 (tirzepatide; Schedule: Prescription) (read November 11, 2026); Ontario e-Formulary: searches for tirzepatide (generic name), Mounjaro and Zepbound (brand name) (read November 11, 2026); ontario.ca: Check medication coverage (searches for Mounjaro, Zepbound, tirzepatide, Wegovy and Ozempic; page dated October 9, 2026) (read November 11, 2026); ontario.ca: Get coverage for prescription drugs (Ontario Drug Benefit program; page dated August 18, 2026) (read November 11, 2026)
Private and workplace plans
The ODB Formulary applies to the ODB program. An employer or other private plan sets its own rules, and having one changes what Ontario offers: "If you have a private plan you are not eligible for OHIP+", and the Trillium Drug Program is for people who don't have "an insurance plan that pays for 100% of your drugs". Manulife, Sun Life and Canada Life put Ozempic on their prior authorization lists: your prescriber sends the insurer's form, and the insurer pays only when its criteria are met. Wegovy is covered only on plans that include it. Ask your insurer about Mounjaro and Zepbound, or check with the Coverage Checker.
Sources: ontario.ca: Learn about OHIP+ (page dated February 11, 2026) (read November 11, 2026); ontario.ca: Trillium Drug Program, who should apply and what you pay (page dated February 11, 2026) (read November 11, 2026); Manulife: Ozempic placed on the prior authorization list (April 5, 2023); coverage subject to plan design (read October 2, 2026); Sun Life: Ozempic prior authorization form 4233-PA-OZE-E (reimbursement only if all listed criteria are met) (read October 2, 2026); Sun Life: optional drug category, prior authorization from October 15, 2024 (August 13, 2024) (read October 2, 2026); Canada Life: Ozempic and Rybelsus added to the prior authorization drug list (November 27, 2023) (read October 2, 2026); Canada Life: Wegovy prior authorization form M6453 ("not covered under all benefit plans") (read October 2, 2026)
Getting a prescription online in Ontario
Each of these drugs needs a prescription: Health Canada's Drug Product Database puts Ozempic, Wegovy, Mounjaro, Zepbound and Apo-Semaglutide in its Prescription schedule. If you don't have a prescriber, our Ontario guides list the online providers that serve Ontario, what they charge and where to fill the prescription.
Sources: Health Canada Drug Product Database: Ozempic, DIN 02471469 (semaglutide; Schedule: Prescription, Schedule D) (read November 11, 2026); Health Canada Drug Product Database: Wegovy, DIN 02528525 (semaglutide; Schedule: Prescription, Schedule D) (read November 11, 2026); Health Canada Drug Product Database: Mounjaro KwikPen, DIN 02551950 (tirzepatide; Schedule: Prescription) (read November 11, 2026); Health Canada Drug Product Database: Zepbound, DIN 02557509 (tirzepatide; Schedule: Prescription) (read November 11, 2026); Health Canada Drug Product Database: Apo-Semaglutide Injection, DIN 02568012 (semaglutide; Schedule: Prescription) (read November 11, 2026)
Where are you in your GLP-1 journey?
Answer a few quick questions — get your cheapest path to a GLP-1 prescription, free.
Frequently asked questions
Is Ozempic covered by OHIP?
No. OHIP covers medically necessary doctor visits and hospital care, and its list of what it does not cover includes "prescription drugs provided in non-hospital settings". Drug coverage comes from the Ontario Drug Benefit program, for the people it covers, or from a private plan.
Sources: ontario.ca: What OHIP covers (page dated November 9, 2026) (read November 13, 2026); ontario.ca: Get coverage for prescription drugs (Ontario Drug Benefit program; page dated August 18, 2026) (read November 11, 2026)
Does the Ontario Drug Benefit program cover Ozempic?
As a Limited Use drug. When we read the e-Formulary on November 13, 2026, the three Ozempic pens (DINs 02471469, 02471477 and 02540258) and the generic semaglutide pens from Apotex (Apo-Semaglutide) and Dr. Reddy's were Limited Use products, with Reason for Use codes 665, 666 and 667. The program pays when the code's published criteria are met and your prescriber gives the code with the prescription, and the amount it pays for an Ozempic pen is the generic pen's Drug Benefit Price.
Sources: Ontario e-Formulary: search for semaglutide (Formulary effective from October 30, 2026) (read November 13, 2026); Ontario e-Formulary: Limited Use note, Reason For Use code 665 (semaglutide 1.34 mg/mL 3 mL pen) (read November 13, 2026); Ontario e-Formulary: Limited Use note, Reason For Use code 666 (semaglutide 1.34 mg/mL 1.5 mL pen) (read November 13, 2026); Ontario e-Formulary: Limited Use note, Reason For Use code 667 (semaglutide 0.68 mg/mL 3 mL pen) (read November 13, 2026); Ontario Drug Benefit Formulary/Comparative Drug Index, Edition 43 (October 27, 2026 version) (read November 11, 2026); Ontario e-Formulary: interchangeable grouping of the semaglutide 1.34 mg/mL 3 mL pens (Ozempic DIN 02471469) (read November 11, 2026)
How much is Ozempic in Ontario without insurance?
The lowest Ozempic price we list in Ontario is $241 at Costco Pharmacy (2mg/1.34mL pen, 1 pen, updated November 2026). The lowest generic semaglutide (Apo-Semaglutide) price we list in Ontario is $88 at Costco Pharmacy (2mg/3mL pen, 1 pen, updated November 2026). A pharmacy may add a dispensing fee. Every pharmacy's price is on Ozempic prices in Ontario.
How much is Mounjaro in Ontario without coverage?
The lowest Mounjaro price we list in Ontario is $288 at Costco Pharmacy (2.5mg/0.6mL pen, 1 pen, updated November 2026). The lowest Zepbound price we list in Ontario is $319.67 at Walmart Pharmacy (2.5mg/0.6mL pen, 1 pen, updated November 2026). A pharmacy may add a dispensing fee. Every pharmacy's price is on Mounjaro prices in Ontario.
Is Mounjaro covered in Ontario?
Not by the Ontario Drug Benefit program. The e-Formulary has no Mounjaro or tirzepatide product, and Ontario's Check medication coverage tool, which also searches the Exceptional Access Program list, finds none. You pay the pharmacy price unless a private plan covers it.
Sources: Ontario e-Formulary: searches for tirzepatide (generic name), Mounjaro and Zepbound (brand name) (read November 11, 2026); ontario.ca: Check medication coverage (searches for Mounjaro, Zepbound, tirzepatide, Wegovy and Ozempic; page dated October 9, 2026) (read November 11, 2026); ontario.ca: Get coverage for prescription drugs (Ontario Drug Benefit program; page dated August 18, 2026) (read November 11, 2026)
Can a doctor apply to the Exceptional Access Program for Mounjaro?
A doctor or nurse practitioner can send the Exceptional Access Program a request for a drug that is not on the Formulary, but the EAP considers a request only for a drug Ontario has decided to fund through it. When we looked on November 11, 2026, Ontario's list of the most common EAP drug products (September 2026 update, not a comprehensive list) had no tirzepatide product, and its coverage tool found no Mounjaro or Zepbound. If you fill the prescription before a decision and the request is not approved, Ontario does not pay you back.
Sources: ontario.ca: Exceptional Access Program, information for health care professionals (page dated November 9, 2026) (read November 11, 2026); ontario.ca: Applying to the Exceptional Access Program (page dated October 20, 2025) (read November 11, 2026); Ontario Exceptional Access Program: EAP Drug List with Drug Identification Numbers (September 2026 update) (read November 11, 2026); ontario.ca: Check medication coverage (searches for Mounjaro, Zepbound, tirzepatide, Wegovy and Ozempic; page dated October 9, 2026) (read November 11, 2026)
Is Wegovy or Zepbound covered in Ontario?
Not by the Ontario Drug Benefit program. The e-Formulary lists Wegovy only as an Off-Formulary Interchangeable product, a status for products that are not ODB benefits, and it has no Zepbound product. A private plan may cover Wegovy if your plan includes it.
Sources: Ontario e-Formulary: Wegovy 4mg/3mL pen, DIN 02528525, product details (read November 13, 2026); Ontario Drug Benefit Formulary/Comparative Drug Index, Edition 43 (October 27, 2026 version) (read November 11, 2026); Ontario e-Formulary: searches for tirzepatide (generic name), Mounjaro and Zepbound (brand name) (read November 11, 2026); Sun Life: optional drug category, prior authorization from October 15, 2024 (August 13, 2024) (read October 2, 2026); Canada Life: Wegovy prior authorization form M6453 ("not covered under all benefit plans") (read October 2, 2026)
Do Ontario seniors pay for Ozempic?
Seniors join the Ontario Drug Benefit program automatically on the first day of the month after they turn 65. Unless they qualify another way or are in the Seniors Co-Payment Program, they pay a deductible each program year, then a co-payment for each prescription; the Seniors Co-Payment Program, for seniors under its income thresholds, has no deductible and a lower co-payment. Ozempic is still a Limited Use drug: the program pays only under the criteria of the pen's Reason for Use code.
Sources: ontario.ca: Get coverage for prescription drugs (Ontario Drug Benefit program; page dated August 18, 2026) (read November 11, 2026); Ontario e-Formulary: search for semaglutide (Formulary effective from October 30, 2026) (read November 13, 2026); Ontario Drug Benefit Formulary/Comparative Drug Index, Edition 43 (October 27, 2026 version) (read November 11, 2026)
Does the Trillium Drug Program cover Ozempic?
People enrolled in the Trillium Drug Program are on the Ontario Drug Benefit program, so the same Formulary applies: Ozempic and generic semaglutide are Limited Use drugs, and Mounjaro, Zepbound and Wegovy are not benefits. Trillium coverage begins once your household has paid its deductible, "usually about 4% of your household income after taxes".
Sources: ontario.ca: Get coverage for prescription drugs (Ontario Drug Benefit program; page dated August 18, 2026) (read November 11, 2026); ontario.ca: Trillium Drug Program, who should apply and what you pay (page dated February 11, 2026) (read November 11, 2026); Ontario e-Formulary: search for semaglutide (Formulary effective from October 30, 2026) (read November 13, 2026); Ontario e-Formulary: searches for tirzepatide (generic name), Mounjaro and Zepbound (brand name) (read November 11, 2026); Ontario e-Formulary: Wegovy 4mg/3mL pen, DIN 02528525, product details (read November 13, 2026)
Sources
- ontario.ca: What OHIP covers (page dated November 9, 2026) (read November 13, 2026): OHIP covers medically necessary visits to a doctor, in person or by video or telephone, and hospital visits and stays. "OHIP does not cover: prescription drugs provided in non-hospital settings".
- ontario.ca: Get coverage for prescription drugs (Ontario Drug Benefit program; page dated August 18, 2026) (read November 11, 2026): Who can qualify: people 65 and older and, before 65, people in a long-term care home or a Community Home for Opportunity, people 24 or younger not covered by a private insurance plan (through OHIP+), people receiving professional home and community care services, Ontario Works or Ontario Disability Support Program benefits, and people enrolled in the Trillium Drug Program. The program is for Ontario residents only, and "prescriptions must be filled in an Ontario pharmacy to be covered". Not covered: "drugs that are not listed on the official Ontario Drug Benefit Formulary/Comparative Drug Index, or are not approved by the Exceptional Access Program". Limited Use drugs and the Reason for Use code; brand-name or generic, "whichever costs less"; the deductible, the co-payment and the program year (August 1 to July 31) for seniors; the Seniors Co-Payment Program.
- Ontario e-Formulary: search for semaglutide (Formulary effective from October 30, 2026) (read November 13, 2026): Limited Use: the Ozempic 1.34 mg/mL 3 mL pen (DIN 02471469), 1.34 mg/mL 1.5 mL pen (02471477) and 0.68 mg/mL 3 mL pen (02540258); Apo-Semaglutide Injection (02568012 and 02568020); Dr. Reddy's Semaglutide Injection (02567806 and 02567814). Off-Formulary Interchangeable: Wegovy (02528525). Open a DIN for its details: the four generic pens have the Formulary Listing Date June 30, 2026.
- Ontario e-Formulary: Limited Use note, Reason For Use code 665 (semaglutide 1.34 mg/mL 3 mL pen) (read November 13, 2026): The plan's published Limited Use criteria for this code; LU Authorization Period: Indefinite.
- Ontario e-Formulary: Limited Use note, Reason For Use code 666 (semaglutide 1.34 mg/mL 1.5 mL pen) (read November 13, 2026): The plan's published Limited Use criteria for this code; LU Authorization Period: Indefinite.
- Ontario e-Formulary: Limited Use note, Reason For Use code 667 (semaglutide 0.68 mg/mL 3 mL pen) (read November 13, 2026): The plan's published Limited Use criteria for this code; LU Authorization Period: Indefinite.
- Ontario Drug Benefit Formulary/Comparative Drug Index, Edition 43 (October 27, 2026 version) (read November 11, 2026): Page 6: Off-Formulary Interchangeability applies "to drug products that are not listed as ODB benefits", and some of those products "may be covered under the ODB program through the EAP". Page 8: the program reimburses "the lowest DBP within an interchangeable category". Page 9: a Limited Use product is reimbursed only when its criteria are met and the prescriber has provided the Reason for Use Code. Page 10: none of the Off-Formulary Interchangeable products "are formulary benefits". Page 20: medically necessary "No Substitution" claims.
- Ontario e-Formulary: searches for tirzepatide (generic name), Mounjaro and Zepbound (brand name) (read November 11, 2026): Each search returns "No drugs found for selected criteria. Please try again using different criteria."
- ontario.ca: Check medication coverage (searches for Mounjaro, Zepbound, tirzepatide, Wegovy and Ozempic; page dated October 9, 2026) (read November 11, 2026): The tool searches the Ontario Drug Benefit Formulary and the Exceptional Access Program list. Mounjaro, Zepbound and tirzepatide: no result. When it finds nothing, Ontario says it could mean the medication "is not on the Ontario Drug Benefit (ODB) Formulary or the Exceptional Access Program (EAP) list, although other programs may offer coverage" or "is new or is being reviewed to decide if it should be added to the ODB Formulary or EAP list". Wegovy (DIN 02528525): not covered. The Ozempic pens and the generic semaglutide pens: may be covered, Limited Use.
- Ontario e-Formulary: Wegovy 4mg/3mL pen, DIN 02528525, product details (read November 13, 2026): Coverage Status: Off-Formulary Interchangeable; Drug Benefit Price or Unit Price: N/A; Amount MOH Pays: N/A; Formulary Listing Date August 31, 2026. A search for Wegovy by brand name finds this product only.
- ontario.ca: Learn about OHIP+ (page dated February 11, 2026) (read November 11, 2026): OHIP+ covers "anyone age 24 years or younger who is not covered by a private plan", with no enrolment; coverage stops on the 25th birthday or when a private plan covers the person; it covers the medications available through the Ontario Drug Benefit program, and the pharmacy fills the prescription "at no charge". "If you have a private plan you are not eligible for OHIP+."
- ontario.ca: Trillium Drug Program, who should apply and what you pay (page dated February 11, 2026) (read November 11, 2026): For households with high prescription-drug costs compared to their income; you should apply if you do not already qualify for the Ontario Drug Benefit program and "do not have an insurance plan that pays for 100% of your drugs". It covers the medications available through the Ontario Drug Benefit program and the Exceptional Access Program. The deductible is "usually about 4% of your household income after taxes"; after it, a co-payment for each drug filled or refilled.
- ontario.ca: Applying to the Exceptional Access Program (page dated October 20, 2025) (read November 11, 2026): Case-by-case consideration for selected drugs not on the Formulary; you must be enrolled in the Ontario Drug Benefit program; "Only a doctor or nurse practitioner can apply"; a decision in 3 days to 6 weeks; if you fill the prescription before the decision and the request is not approved, you "will not receive any coverage of your out-of-pocket costs".
- ontario.ca: Exceptional Access Program, information for health care professionals (page dated November 9, 2026) (read November 11, 2026): The EAP "facilitates patient access to drugs not funded on the Ontario Drug Benefit (ODB) Formulary"; the patient must be eligible for the Ontario Drug Benefit program; a request is considered only for a drug the Executive Officer has decided to fund through the EAP; "Approval is not guaranteed."
- Ontario e-Formulary: interchangeable grouping of the semaglutide 1.34 mg/mL 3 mL pens (Ozempic DIN 02471469) (read November 11, 2026): Ozempic, Apo-Semaglutide Injection and Dr. Reddy's Semaglutide Injection are one interchangeable grouping; the "Amount MOH Pays" for the Ozempic pen equals the Drug Benefit Price of the generic pens. The groupings of Ozempic DINs 02471477 and 02540258 show the same.
- Health Canada Drug Product Database: Mounjaro KwikPen, DIN 02551950 (tirzepatide; Schedule: Prescription) (read November 11, 2026)
- Ontario Exceptional Access Program: EAP Drug List with Drug Identification Numbers (September 2026 update) (read November 11, 2026): An Excel list of "the most common drug products currently funded through the EAP"; it says it is not a comprehensive list. No semaglutide or tirzepatide product. Its notes say prescribers can send the EAP a request for any drug that is not on the Formulary, and that not every drug is funded.
- Health Canada Drug Product Database: Zepbound, DIN 02557509 (tirzepatide; Schedule: Prescription) (read November 11, 2026)
- Manulife: Ozempic placed on the prior authorization list (April 5, 2023); coverage subject to plan design (read October 2, 2026): Live page blocks automated access; read via the Wayback snapshot of 2026-06-19.
- Sun Life: Ozempic prior authorization form 4233-PA-OZE-E (reimbursement only if all listed criteria are met) (read October 2, 2026)
- Sun Life: optional drug category, prior authorization from October 15, 2024 (August 13, 2024) (read October 2, 2026): Read via the Wayback snapshot of 2026-06-09.
- Canada Life: Ozempic and Rybelsus added to the prior authorization drug list (November 27, 2023) (read October 2, 2026)
- Canada Life: Wegovy prior authorization form M6453 ("not covered under all benefit plans") (read October 2, 2026)
- Health Canada Drug Product Database: Ozempic, DIN 02471469 (semaglutide; Schedule: Prescription, Schedule D) (read November 11, 2026)
- Health Canada Drug Product Database: Wegovy, DIN 02528525 (semaglutide; Schedule: Prescription, Schedule D) (read November 11, 2026)
- Health Canada Drug Product Database: Apo-Semaglutide Injection, DIN 02568012 (semaglutide; Schedule: Prescription) (read November 11, 2026)
Health Canada compliance: GLP1Prices.ca displays drug names, prices, and quantities only. We do not make therapeutic claims. This website does not provide medical advice. Consult your healthcare provider about medication options.
Related
- BC PharmaCare coverage · What BC PharmaCare pays for the same drugs.
- Alberta Blue Cross coverage · What Alberta's government drug plans pay for the same drugs.
- RAMQ coverage in Quebec · What RAMQ's List of Medications says for the same drugs.
- Manitoba Pharmacare coverage · What Manitoba Pharmacare pays for the same drugs.
- Saskatchewan Drug Plan coverage · What the Saskatchewan Drug Plan pays for the same drugs.
- Nova Scotia Pharmacare coverage · What Nova Scotia Pharmacare pays for the same drugs.
- Generic Ozempic cost in Ontario · Apo-Semaglutide prices at Ontario pharmacies.
- Coverage Checker · Check what your own plan covers.
Update log
- New page: what the Ontario Drug Benefit program pays for Ozempic, generic semaglutide, Mounjaro, Wegovy and Zepbound, from Ontario's Formulary and program pages, with cash prices and prescription options.
- Added a yes-or-no answer for each drug at the top of the page. Re-checked that day: the e-Formulary listings for Ozempic, generic semaglutide and Wegovy, the three Limited Use notes, and OHIP's list of what it does not cover.